Medications and Pharmacology — All Questions

Under 49 CFR 391.41(b)(12), what is required for a driver using a Schedule II through V medication to meet the prescription exception?

During the health history review, a driver discloses taking a medication but cannot remember the name or dosage. What should the examiner do?

Which of the following substances is ALWAYS disqualifying for a CMV driver under FMCSA regulations, regardless of state law?

A CDL applicant reports using marijuana under a state-issued medical marijuana card for chronic pain. What is the appropriate certification determination?

Which of the following is classified as a Schedule I controlled substance under FMCSA guidelines?

Which of the following substances is classified as Schedule I and always disqualifying for CMV drivers?

A driver admits to using a hallucinogenic substance. Under the FMCSA drug schedule framework, how are hallucinogenic substances classified?

Which of the following statements about Schedule I substances and CMV driving is TRUE?

Which category of substances listed in 21 CFR 1308.11 (Schedule I) includes hallucinogens, opiates, and opiate derivatives?

A driver reports living in a state where recreational marijuana is legal and uses cannabis edibles nightly for sleep. What is the certification determination?

A driver is prescribed a Schedule IV medication for anxiety. Which of the following must the ME verify to determine if the prescription exception is met?

Under FMCSA regulations, which of the following is NOT a Schedule I controlled substance?

A CMV driver with a stable mood disorder has been taking sertraline (Zoloft) 100 mg daily for 2 years with no side effects. What is the appropriate certification decision?

According to FMCSA guidance, which class of antidepressants is noted as having fewer side effects compared to first-generation antidepressants, while still requiring case-by-case evaluation?

A driver is prescribed citalopram (Celexa) 20 mg daily for depression. He reports occasional mild nausea as a side effect but no drowsiness. What is the appropriate action?

Which of the following psychiatric medication scenarios would be MOST acceptable for CMV driver certification?

When evaluating a driver who takes an anxiolytic medication, what characteristic of the anxiolytic does the handbook identify as a key consideration?

Under FMCSA guidelines, what is the primary concern regarding tricyclic antidepressant (TCA) use in CMV drivers?

A driver with a history of bipolar disorder is stable on lithium with therapeutic blood levels and a supportive psychiatrist letter. What should the examiner do?

A CMV driver has been using over-the-counter ibuprofen (Advil) 400 mg three times daily for chronic knee pain. What is the FMCSA certification determination?

A driver reports his physician prescribed Suboxone (buprenorphine/naloxone) for opioid use disorder. He has been stable on the medication for 1 year. What is the certification determination?

A CMV driver presents for DOT examination and reports using CBD oil purchased at a health food store. What should the medical examiner consider?

A CMV driver is taking amphetamine/dextroamphetamine (Adderall) for adult ADHD. How should the medical examiner evaluate this?

A driver reports being on a stable dose of warfarin (Coumadin) for atrial fibrillation. His most recent INR is 2.5. What is the certification determination?

A driver on warfarin presents with an INR of 4.5. What should the medical examiner do?

Which of the following cardiac medications is generally acceptable for CMV drivers under FMCSA guidelines?

A CMV driver is taking atenolol 50 mg daily for hypertension. He reports occasional fatigue but no dizziness or syncope. What is the appropriate action?

What INR range is considered therapeutic for a CMV driver on warfarin under FMCSA guidelines?

A driver is taking a direct oral anticoagulant (DOAC) such as apixaban (Eliquis) instead of warfarin. What should the examiner consider?

When evaluating a CMV driver’s medication list, which of the following factors should the medical examiner assess according to FMCSA guidelines?

Under 49 CFR 391.41(b)(12), which category of drugs cannot be prescribed for any purpose under Federal law and automatically precludes physical qualification?

Marijuana is classified as a Schedule I drug. Can a CMV driver be physically qualified if they use marijuana that is legal in their state?

What three conditions must be met for the prescription exception to allow certification of a driver using a Schedule II through V controlled substance?

FMCSA has noted that treatment with methadone does NOT automatically preclude CMV certification. What must the ME confirm?

Suboxone (buprenorphine and naloxone) is classified under which drug schedule?

The drug schedules (I through V) are based on addiction potential and medical use. What are they NOT based on?

What optional form can MEs use to request information from a prescribing practitioner about scheduled medications?

CBD products containing less than 0.3% THC by dry weight are treated how under 391.41(b)(12)?

Why is the use of CBD products considered risky for CMV drivers despite the 0.3% THC threshold?

Barbiturates and related sedative hypnotics may cause what level of impairment compared to benzodiazepines?

Which side effects of scheduled drugs should the ME specifically assess when determining whether a driver can safely operate a CMV?

The demands of commercial driving may complicate medication adherence in which ways?

FMCSA does not have a physical qualification standard for which category of drugs?

Second generation antihistamines differ from first generation antihistamines in what important way for CMV drivers?

CNS stimulants such as dextroamphetamine and methylphenidate are controlled substances. What must their use satisfy?

An ME observes signs suggesting a driver may not have disclosed use of a scheduled substance. What action can the ME take?

The non-DOT drug testing process requested by an ME does NOT require the use of which professional?

Disclosure of prior illegal drug use during the DOT physical examination has what effect on medical certification?

Scheduled drugs may cause symptoms that adversely affect CMV safety including altered alertness and temporary confusion. What other effects are listed?

When evaluating a driver’s use of a hypnotic medication for insomnia, what specific pharmacological property should the ME consider?

How can the physical demands of commercial driving affect a driver’s need for pain medication?

A driver is being evaluated for narcolepsy. According to the handbook, narcolepsy is associated with which primary risk for CMV operation?

An ME receives conflicting reports from a driver’s cardiologist and primary care provider. The cardiologist clears the driver, but the PCP has concerns about medication side effects. Who makes the final certification determination?

When a driver discloses use of diet supplements on the Medical Examination Report Form, what should the ME do?

What is the primary function of a laboratory information system (LIS) in a clinical laboratory?

When obtaining a SAMPLE history, which of the following is an example of relevant family history information?

A CMV driver presents for a DOT physical and reports taking methadone prescribed by a pain management specialist. The prescriber has confirmed the driver can safely operate a CMV. Who makes the final medical certification determination?

You respond to a 62-year-old male with severe abdominal pain. When gathering his past medical history, he reports having his gallbladder removed three years ago and an appendectomy as a teenager. Why is this surgical history significant to your assessment?

The concept of treating all blood and body fluids as potentially infectious, regardless of the patient’s diagnosis, is the foundation of which infection control practice?

Body substance isolation (BSI) is an infection control strategy that requires EMS providers to do which of the following?

An EMT is splashed in the eyes with a patient’s blood during an emergency procedure. After flushing the eyes with clean water, what is the most important next step?

The Ryan White CARE Act is significant to EMS providers because it provides which of the following?

After transporting a patient with active tuberculosis, the EMT must ensure the ambulance stretcher and surfaces are properly cleaned. Which level of cleaning is most appropriate for this situation?

You arrive at a motorcycle crash and find the rider unconscious with a full-face helmet still in place. What is the correct approach to helmet removal?

When operating at a nighttime roadway incident, which piece of personal protective equipment is required to increase the EMT’s visibility to passing traffic?

An EMT is preparing to assist with a childbirth in the field where significant exposure to blood and amniotic fluid is expected. In addition to gloves, the EMT applies a second pair of gloves over the first. What is the primary purpose of this double gloving technique?

What is the correct sequence for donning personal protective equipment before entering a scene with potential body fluid exposure?

A patient is breathing at a rate of 8 breaths per minute with a tidal volume of approximately 300 mL per breath. What is this patient’s approximate minute volume, and is it adequate?

A driver is prescribed methadone by a licensed medical practitioner for chronic pain management. According to FMCSA guidance, what is the correct approach to evaluating this driver’s certification status?

A driver uses a CBD product labeled as containing less than 0.3% THC by dry weight. The ME is concerned about the accuracy of the product labeling. What does the handbook indicate about CBD products?

A driver is taking Suboxone (buprenorphine/naloxone) prescribed by a licensed medical practitioner for opioid use disorder treatment. According to FMCSA guidance, what is the driver’s certification status?

An ME suspects a driver may not have disclosed all medications during the health history review. Which optional FMCSA form can the ME use, with the driver’s consent, to request additional medication information from the treating provider?

A CMV driver with Stage 2 hypertension (BP 168/104 mmHg) is started on an antihypertensive medication. At the follow-up visit three months later, BP is 136/86 mmHg and treatment is well tolerated. What is the maximum certification period the ME may issue?

According to FMCSA guidance, what should be the primary basis of the ME’s certification decision for a driver on anticoagulant therapy?

A CMV driver is prescribed a tricyclic antidepressant for chronic depression. His treating physician reports stable mood and no significant side effects. Which classification of antidepressant does this represent, and what should the ME consider?

Which of the following side effects of antipsychotic medications (neuroleptics) may interfere with safe CMV driving?

A CMV driver is prescribed zolpidem for insomnia. The ME is evaluating whether this medication is likely to interfere with safe driving. According to FMCSA guidance, which of the following is true about non-benzodiazepine sedative hypnotics such as zolpidem?

A CMV driver is taking oxycodone (Schedule II) for chronic back pain prescribed by a licensed medical practitioner who is familiar with the driver’s medical history. The prescribing practitioner has provided a completed MCSA-5895 form stating the medication will not adversely affect driving ability. However, during the physical examination, the ME observes that the driver appears drowsy and has slowed reaction times. What should the ME do?

A CMV driver with a diagnosis of adult ADHD is taking methylphenidate (a Schedule II CNS stimulant) prescribed by a psychiatrist. The driver also takes an opioid pain medication (Schedule II) prescribed by a different physician for a separate condition. The ADHD treatment has been stable for 2 years with no adverse side effects. What is the ME’s primary concern when evaluating this driver?

A CMV driver is being treated with a benzodiazepine (Schedule IV) for an anxiety disorder. The prescribing physician has provided documentation stating the medication will not adversely affect driving ability. The ME notes the benzodiazepine has a half-life of 12 hours and the driver reports occasional daytime drowsiness. In evaluating this driver, which combination of factors is most important for the ME to consider?

A driver with a history of deep vein thrombosis is currently on anticoagulant therapy. The driver’s cardiologist reports the treatment is effective and stable. The driver also has Stage 1 hypertension (BP reading 148/94 at the examination). When determining the certification period, the ME must weigh both conditions. What is the correct approach?

A driver is taking a prescribed medication that causes drowsiness. On what should the ME base the certification decision?

According to the handbook, how should anticoagulant therapy be evaluated during a physical qualification examination?

A CMV driver takes a first-generation antihistamine at 10 PM before bed. Based on FMCSA guidance, when might the sedating effects still impair the driver’s ability to safely operate a CMV?

Under 49 CFR 391.41(b)(12), which schedule of controlled substances has no accepted medical use and is always disqualifying?

A driver on multiple medications for cardiovascular disease asks whether the medications are safe for commercial driving. What should the ME advise?